Authors/Disclosures
|
Jacqueline Montes, PT, EdD, NCS
(Columbia University Medical Center)
|
Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Seth A. Kareus, MD, FAAN
(SCL Health)
|
No disclosure on file |
|
Steven M. Albert, PhD, MSPH, FAAN
(Univ of Pittsburgh/School of Public Hlth)
|
No disclosure on file |
|
Hiroshi Mitsumoto, MD, FAAN
(Neurological Institute (NI-9))
|
Dr. Mitsumoto has nothing to disclose. |
|
Paul H. Gordon, MD, PhD, FAAN
|
No disclosure on file |
|
|
No disclosure on file |